Really and this is just what I understood is the only thing that Orphan Drug does is to put it into a category of a smaller group of patients (diseases that are faster in reaction time). Seems to me with what she explained was that the trial period was the same, just the category was different.
I learned so much today from talking to the FDA and I have to say that they were wonderful explaining to me.
Market Data 
Markets 
AI
